PYRITIGMIN RIVA 1.5: Rivastigmine Capsules for Alzheimer's & Parkinson's Dementia

 PYRITIGMIN RIVA 1.5, manufactured by Steris Healthcare, contains Rivastigmine 1.5 mg in capsule form, a cholinesterase inhibitor prescribed for the symptomatic treatment of mild to moderate dementia associated with Alzheimer's disease, as well as dementia related to Parkinson's disease. It works by supporting communication between nerve cells in the brain, helping to improve or stabilize memory, thinking, and daily functioning in affected patients. It does not cure the underlying condition but is widely used to help manage cognitive symptoms and slow functional decline in the earlier stages of dementia.

Why It's Important

Dementia progressively impairs memory, reasoning, and independence, placing significant strain on both patients and caregivers. Early and consistent treatment with cholinesterase inhibitors like rivastigmine can meaningfully slow symptom progression, helping patients retain daily functioning and quality of life for longer. Since dosage typically starts low and is gradually titrated upward, PYRITIGMIN RIVA 1.5 serves as an important starting or maintenance strength, allowing physicians to balance therapeutic benefit against tolerability, especially in elderly patients who may be more sensitive to side effects.

Key Benefits 

What are the benefits?

  • Helps improve or stabilize memory and cognitive function
  • Supports daily functioning in mild to moderate Alzheimer's dementia
  • Useful in managing dementia associated with Parkinson's disease
  • Available in lower starting strength for gradual, tolerable titration
  • Manufactured under WHO-GMP and ISO 9001:2018 certified facility standards by Steris Healthcare, ensuring consistent quality and reliability

Side Effects

Common side effects include nausea, vomiting, loss of appetite, dizziness, and mild stomach upset, particularly during the initial dose-titration phase.

Serious Side Effects 

Patients should seek prompt medical attention for signs of severe dehydration from persistent vomiting, significant weight loss, slow heart rate, fainting, or signs of gastrointestinal bleeding such as black stools.

Available Substitute 

Several branded Rivastigmine capsule and patch formulations are available in the Indian market at comparable strengths. Switching brands or formulations should only be done under physician guidance.

Dosage Guidelines 

Dosage is individualized by the physician, typically starting at a low strength and gradually increased based on tolerability. It is taken with food, morning and evening, to reduce gastrointestinal side effects. Missed doses should not be doubled.

Precautions & Warnings

Use with caution in patients with cardiac conduction abnormalities, active peptic ulcer disease, asthma, or urinary obstruction. Inform your doctor of all current medications before starting therapy.

Mechanism of Action

Rivastigmine inhibits both acetylcholinesterase and butyrylcholinesterase enzymes, reducing the breakdown of acetylcholine in the brain. This increases acetylcholine availability at nerve synapses, supporting improved neurotransmission involved in memory and cognitive processing.

Conclusion

PYRITIGMIN RIVA 1.5 by Steris Healthcare offers a clinically established option for managing cognitive symptoms of Alzheimer's and Parkinson's-related dementia. Treatment should be guided by a physician, with gradual dose titration to optimize benefit and tolerability.

Comments

Popular posts from this blog

Steris Healthcare: Committed to Quality Healthcare and Pharmaceutical Excellence

N-Acetyl L-Cysteine (NAC), Pine Bark Extract and Resveratrol Tablets for Daily Wellness